Check Claims Before You Publish

Visual summary

Graph: OpenAlex top-match metrics (works_count = 7; cited_by_count = 178; h_index = 6) — these are the recorded bibliometric indicators for the best-matching identity across available metadata.

Primary evidence (selected)

• OpenAlex author metadata: top match 'Laura Isabel López-Moreno' with works_count=7, cited_by_count=178, h_index=6; topic weights point to Biology/Bacteria/Antibiotics — implies activity within microbiology/AMR collaborative networks (OpenAlex metadata).
• Microbial Genomics 2026 (DOI 10.1099/mgen.0.001639): collaborative genomic + phenotypic study of 136 Mexican clinical Pseudomonas aeruginosa isolates reporting lineage-specific non-carbapenemase resistance mechanisms, high frequency of disruptive oprD variants, and efflux-pump upregulation under antibiotic exposure; authors explicitly document limitations (variable antibiotic exposures, small expression subset n=18, lack of AmpC and clinical-outcome linkage).

Evidence-based strengths

• Participation in collaborative, multi-center surveillance studies that use modern genomic tools (WGS, resistome annotation, phylogenomics) — indicates technical competence with high-throughput sequencing pipelines and interpretive frameworks.
• Co-authorship on a 2026 Microbial Genomics paper with transparent methods and data deposition (NCBI SRA accession PRJNA1211528), which increases reproducibility and reuse potential.
• Work focuses on clinically-relevant antimicrobial resistance topics (P. aeruginosa carbapenem resistance), yielding applied translational value for surveillance and infection control.

Evidence-based limitations & blindspots

• Bibliometric footprint is modest: works_count and citation totals align with early-career or collaborative contributor roles rather than an extensive independent program of research (OpenAlex metrics).
• Author disambiguation uncertainty: multiple similar name records exist (OpenAlex shows alternate matches), so per-author metrics may be fragmented or conflated; confirm with ORCID/institution data for firm attribution.
• Primary high-quality paper reports acknowledged limitations: small gene-expression sample (n=18), variable antibiotic exposures across isolates, lack of AmpC data and no clinical-outcome linkage — these constrain causal inference and generalizability beyond studied Mexican centers.
• No persistent institutional affiliation listed in OpenAlex or in the provided author metadata — reduces transparency about independent lab leadership or PI status and complicates assessment of resources and supervisory role.

Interpretation & recommendation

Taken together, available data portray Laura Isabel López-Moreno as an engaged collaborator in multi-author antimicrobial resistance surveillance projects with demonstrable experience in genomic and phenotypic methods. The technical quality of the 2026 Microbial Genomics study is high (comprehensive pipelines, data deposition) but the author's independent leadership record appears limited in the public metadata. For evaluations (hiring, grants, peer review) I recommend: (1) confirming identity disambiguation via ORCID/institutional CV; (2) requesting role descriptions in multi-author studies (contribution statements); and (3) seeking follow-up publications with expanded expression/MIC-linked clinical outcome data to elevate independent scientific impact.

Citations used